Cargando…
Switching from Multiplex to Multimodal Colorimetric Lateral Flow Immunosensor
Multiplex lateral flow immunoassay (LFIA) is largely used for point-of-care testing to detect different pathogens or biomarkers in a single device. The increasing demand for multitargeting diagnostics requires multi-informative single tests. In this study, we demonstrated three strategies to upgrade...
Autores principales: | Cavalera, Simone, Di Nardo, Fabio, Forte, Luca, Marinoni, Francesca, Chiarello, Matteo, Baggiani, Claudio, Anfossi, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698945/ https://www.ncbi.nlm.nih.gov/pubmed/33218125 http://dx.doi.org/10.3390/s20226609 |
Ejemplares similares
-
Ten Years of Lateral Flow Immunoassay Technique Applications: Trends, Challenges and Future Perspectives
por: Di Nardo, Fabio, et al.
Publicado: (2021) -
Multiplex Lateral Flow Immunoassay: An Overview of Strategies towards High-throughput Point-of-Need Testing
por: Anfossi, Laura, et al.
Publicado: (2018) -
Dual lateral flow optical/chemiluminescence immunosensors for the rapid detection of salivary and serum IgA in patients with COVID-19 disease
por: Roda, Aldo, et al.
Publicado: (2021) -
Enzyme Immunoassay for Measuring Aflatoxin B1 in Legal Cannabis
por: Di Nardo, Fabio, et al.
Publicado: (2020) -
Effect of Polymerization Time on the Binding Properties of Ciprofloxacin-Imprinted nanoMIPs Prepared by Solid-Phase Synthesis
por: Chiarello, Matteo, et al.
Publicado: (2021)